Sep 2026· Cancer Research· pp. OF1-OF17· 0 citations
Medicine
TL;DR
This study characterizes the spatial heterogeneity of tumor states and TME programs in CRC and provides a translational framework for improved CRC stratification and immunotherapy guidance.
Abstract
Colorectal cancers (CRC) with microsatellite stability (MSS) and instability (MSI) differ in tumor microenvironment (TME) composition and clinical treatment and outcomes. While MSI CRC is considered to be sensitive to immune checkpoint blockade therapy, MSS tumors are largely resistant. Characterizing the spatial TME differences between MSS and MSI tumors could provide insights to improve immunotherapy efficacy. Here, we profiled an integrated single-cell and spatial transcriptomic atlas of MSS and MSI CRC across independent cohorts and platforms. Spatial mapping revealed subtype-specific boundary microenvironments coupled to distinct malignant epithelial states. Cancer cells in a fully mesenchymal epithelial-mesenchymal-transition (EMT) state (EMT-II subtype) were enriched near the tumor boundary in MSS, while cancer cells with metabolically active EMT programs (EMT-III subtype) and interferon states were enriched in MSI and displayed a more dispersed distribution. A boundary-proximal interaction network selectively enriched in MSS was characterized by the accumulation of glial-like and tip-like cells around tumor boundary, which preferentially co-localized with EMT-II state tumor cells. The network was linked to extracellular matrix remodeling and EMT malignant cell states. Further, development of a cross-platform classifier TiGELR, a machine learning-derived tip cell-glial cell-EMT II tumor cell ligand-receptor signature, accurately distinguished MSS from MSI and stratified immunotherapy outcomes. Together, this study characterizes the spatial heterogeneity of tumor states and TME programs in CRC and provides a translational framework for improved CRC stratification and immunotherapy guidance.
Stroma-dominant CRC is characterized as a spatially organized ecosystem in which a CAF-rich compartment is associated with stress-adapted cancer cell programs, and its poor prognosis may involve not only stromal abundance but also a morphology-associated cancer cell state detectable after dissemination.
S. Kitagawa, N. Mimura, Hironobu Kambara et al.· Biomolecules· 0 citations
A large-scale, multi-layered analytical pipeline connects single-cell resolution with spatial and histological data, produces validated prognostic tools and nominates PVR/CD155 as a tumor cell-intrinsic EMT-associated target candidate for gastric cancer.
Jian-Wen Li, Zi-Tong Qin, Ting Wang et al.· Frontiers in Immunology· 0 citations
A site-specific regulatory mechanism of the macrophage-endothelial niche is revealed, offering a novel and clinically significant biomarker for CRC prognosis.
Glioblastoma, IDH-wildtype, CNS WHO grade 4 (GBM) is the most aggressive primary malignant brain tumor in adults, with a median overall survival of approximately 15 months despite maximal surgical resection, radiotherapy, and chemotherapy with temozolomide. This therapeutic resistance is increasingly attributed to the...
Jia-Na Lei, Mei Lao, Zhuo-Na Ni et al.· Frontiers in Immunology· 0 citations
Upper tract urothelial carcinoma (UTUC) is characterized by a high incidence of muscle invasion and distinct molecular heterogeneity, with tumor microenvironment (TME) heterogeneity playing a pivotal role in its malignant progression. However, the spatial distribution patterns of functional cell populations in UTUC and...
Jiang Liu, Yang-Yang Wei, Yi Liu et al.· Pharmacological Research· 0 citations
This work systematically profile paired primary PDAC lesions and matched liver metastases, mapping their distinct cell subpopulations and spatially resolved transcriptional landscapes, and identifies the indispensable role of MIC subpopulation in fueling liver metastasis.
Xi Chen· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.